SBIR Phase II: Leveraging Health Information Technology to Improve Communication Between Cancer Patients and Providers

SBIR 第二阶段：利用健康信息技术改善癌症患者和提供者之间的沟通

• 批准号: 1534685
• 负责人: Howard Isenstein
• 金额: $ 72.52万
• 依托单位: Care Progress, LLC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-15 至 2018-11-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1534685&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Leveraging; Health

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improve outcomes for patients in cancer treatment. Such patients often suffer from side effects of cancer treatment, such as dehydration and nausea. By enhancing communication between providers and patients, the project seeks to better manage such symptoms and thereby improve outcomes for patients, including lower readmission and emergency department visits and associated costs for Medicare, Medicaid and private payors. The project will enhance scientific and technological understanding by creating a knowledge base of symptoms patients are experiencing. If we are successful we will be able to improve cancer treatment and lower costs in the United States at a time when the number of cancer patients is projected to increase significantly. These benefits are likely to create strong commercial demand for our product from hospitals, Accountable Care Organizations and outpatient cancer centers, which are increasingly under pressure by legislation and private payors to reduce treatment costs. The proposed project seeks to address the problem of poor communication between providers and cancer patients (which is partially responsible for extremely high readmission and emergency department visits) who are experiencing nausea, dehydration, neutropenia and other side effects. The project seeks to obtain patient symptoms and report them to providers for potential earlier intervention and outcome improvement. The methods to be employed include assembling an expert panel, creating software and then conducting a feasibility trial. Key goals include demonstrating the feasibility of obtaining patient symptoms and that providers find the information useful and actionable

该小企业创新研究 (SBIR) 第二阶段项目的更广泛影响/商业潜力是改善癌症治疗患者的结果。此类患者经常遭受癌症治疗的副作用，例如脱水和恶心。通过加强医疗服务提供者和患者之间的沟通，该项目旨在更好地管理此类症状，从而改善患者的治疗结果，包括减少再入院和急诊科就诊以及医疗保险、医疗补助和私人付款人的相关费用。该项目将通过创建患者正在经历的症状的知识库来增强科学和技术的理解。如果我们取得成功，我们将能够在美国癌症患者数量预计将大幅增加的情况下改善癌症治疗并降低成本。这些好处可能会为医院、责任医疗组织和门诊癌症中心创造对我们产品的强劲商业需求，这些机构越来越受到立法和私人付款人降低治疗成本的压力。拟议的项目旨在解决医疗服务提供者和正在经历恶心、脱水、中性粒细胞减少和其他副作用的癌症患者之间沟通不畅的问题（这在一定程度上导致了极高的再入院和急诊就诊率）。该项目旨在获取患者症状并将其报告给提供者，以便进行可能的早期干预和改善结果。所采用的方法包括组建专家小组、创建软件，然后进行可行性试验。主要目标包括证明获取患者症状的可行性以及提供者认为这些信息有用且可操作